Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, Schermer TR, Biermans MC.

Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.

PMID:
29335324
2.

Adherence to chronic kidney disease guidelines in primary care patients is associated with comorbidity.

van Dipten C, van Berkel S, van Gelder VA, Wetzels JFM, Akkermans RP, de Grauw WJC, Biermans MCJ, Scherpbier-de Haan ND, Assendelft WJJ.

Fam Pract. 2017 Aug 1;34(4):459-466. doi: 10.1093/fampra/cmx002.

PMID:
28207923
3.

Web-based consultation between general practitioners and nephrologists: a cluster randomized controlled trial.

van Gelder VA, Scherpbier-de Haan ND, van Berkel S, Akkermans RP, de Grauw IS, Adang EM, Assendelft PJ, de Grauw WJC, Biermans MCJ, Wetzels JFM.

Fam Pract. 2017 Aug 1;34(4):430-436. doi: 10.1093/fampra/cmw131.

PMID:
28158576
4.

Quality of chronic kidney disease management in primary care: a retrospective study.

Van Gelder VA, Scherpbier-De Haan ND, De Grauw WJ, Vervoort GM, Van Weel C, Biermans MC, Braspenning JC, Wetzels JF.

Scand J Prim Health Care. 2016;34(1):73-80. doi: 10.3109/02813432.2015.1132885. Epub 2016 Feb 6.

5.

[Timely referral for predialysis; multiple players in the field].

Scherpbier-de Haan ND, de Grauw WJ.

Ned Tijdschr Geneeskd. 2015;159:A9333. Dutch.

PMID:
26200427
6.

Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice.

Luijks HD, de Grauw WJ, Bor JH, van Weel C, Lagro-Janssen AL, Biermans MC, Schermer TR.

NPJ Prim Care Respir Med. 2015 Apr 23;25:15032. doi: 10.1038/npjpcrm.2015.32.

7.

Organizational determinants of high-quality routine diabetes care.

van Doorn-Klomberg AL, Braspenning JC, Wolters RJ, Bouma M, de Grauw WJ, Wensing M.

Scand J Prim Health Care. 2014 Sep;32(3):124-31. doi: 10.3109/02813432.2014.960252. Epub 2014 Sep 29.

8.

Diabetes-related distress, insulin dose, and age contribute to insulin-associated weight gain in patients with type 2 diabetes: results of a prospective study.

Jansen HJ, Vervoort GM, de Haan AF, Netten PM, de Grauw WJ, Tack CJ.

Diabetes Care. 2014 Oct;37(10):2710-7. doi: 10.2337/dc13-1205. Epub 2014 Jul 10.

PMID:
25011948
9.

Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT).

de Wit HM, Vervoort GM, Jansen HJ, de Grauw WJ, de Galan BE, Tack CJ.

Diabetologia. 2014 Sep;57(9):1812-9. doi: 10.1007/s00125-014-3302-0. Epub 2014 Jun 20.

PMID:
24947583
10.

Effect of shared care on blood pressure in patients with chronic kidney disease: a cluster randomised controlled trial.

Scherpbier-de Haan ND, Vervoort GM, van Weel C, Braspenning JC, Mulder J, Wetzels JF, de Grauw WJ.

Br J Gen Pract. 2013 Dec;63(617):e798-806. doi: 10.3399/bjgp13X675386.

11.

Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study.

van Gelder VA, Scherpbier-de Haan ND, de Grauw WJ, O'Callaghan CA, Wetzels JF, Lasserson DS.

BMJ Open. 2013 Sep 25;3(9):e003631. doi: 10.1136/bmjopen-2013-003631.

12.

Initial implementation of a web-based consultation process for patients with chronic kidney disease.

Scherpbier-de Haan ND, van Gelder VA, Van Weel C, Vervoort GM, Wetzels JF, de Grauw WJ.

Ann Fam Med. 2013 Mar-Apr;11(2):151-6. doi: 10.1370/afm.1494.

13.

Patients' and partners' illness perceptions in screen-detected versus clinically diagnosed type 2 diabetes: partners matter!

Klein Woolthuis EP, de Grauw WJ, Cardol M, van Weel C, Metsemakers JF, Biermans MC.

Fam Pract. 2013 Aug;30(4):418-25. doi: 10.1093/fampra/cmt003. Epub 2013 Feb 13.

PMID:
23407657
14.

Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up.

Klein Woolthuis EP, de Grauw WJ, van Keeken SM, Akkermans RP, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2013 Jan-Feb;11(1):20-7. doi: 10.1370/afm.1460.

15.

A pharmacy medication alert system based on renal function in older patients.

Geerts AF, Scherpbier-de Haan ND, de Koning FH, van der Sterren TM, van Weel C, Vervoort GM, de Smet PA, de Grauw WJ.

Br J Gen Pract. 2012 Aug;62(601):e525-9. doi: 10.3399/bjgp12X653561.

16.

Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.

Ramos GF, Kuiper S, Dompeling E, van Asselt AD, de Grauw WJ, Knottnerus JA, van Schayck OC, Schermer TR, Severens JL.

BMC Med Res Methodol. 2011 Nov 9;11:150. doi: 10.1186/1471-2288-11-150.

17.

Opportunistic screening for type 2 diabetes in primary care.

Klein Woolthuis EP, de Grauw WJ, van Weel C.

Lancet. 2010 Aug 28;376(9742):683-4. doi: 10.1016/S0140-6736(10)61332-3. No abstract available.

PMID:
20801397
18.

[Acute renal failure due to RAAS-inhibitors combined with dehydration].

Scherpbier ND, de Grauw WJ, Wetzels JF, Vervoort GM.

Ned Tijdschr Geneeskd. 2010;154:A1548. Dutch.

PMID:
20699027
19.

Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2009 Sep-Oct;7(5):422-30. doi: 10.1370/afm.997.

20.

Patient-oriented intervention in addition to centrally organised checkups improves diabetic patient outcome in primary care.

Meulepas MA, Braspenning JC, de Grauw WJ, Lucas AE, Wijkel D, Grol RP.

Qual Saf Health Care. 2008 Oct;17(5):324-8. doi: 10.1136/qshc.2006.021204.

PMID:
18842969
21.

Prescribing quality indicators of type 2 diabetes mellitus ambulatory care.

Martirosyan L, Braspenning J, Denig P, de Grauw WJ, Bouma M, Storms F, Haaijer-Ruskamp FM.

Qual Saf Health Care. 2008 Oct;17(5):318-23. doi: 10.1136/qshc.2007.024224.

PMID:
18842968
22.

Screening for type 2 diabetes in primary care using a stepwise protocol: the Diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Prim Care Diabetes. 2007 Dec;1(4):199-202. doi: 10.1016/j.pcd.2007.09.002. Epub 2007 Oct 30.

PMID:
18632046
23.

Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Fam Pract. 2007 Jun;24(3):230-6. Epub 2007 May 16.

PMID:
17510087
24.

Time to move from serum creatinine to eGFR.

Bilo HJ, Logtenberg SJ, de Grauw WJ, Kleefstra N, Wolffenbuttel BH.

Diabet Med. 2007 May;24(5):571-2; author reply 572-3. No abstract available.

PMID:
17470193
25.

Logistic support service improves processes and outcomes of diabetes care in general practice.

Meulepas MA, Braspenning JC, de Grauw WJ, Lucas AE, Harms L, Akkermans RP, Grol RP.

Fam Pract. 2007 Feb;24(1):20-5. Epub 2006 Nov 1.

PMID:
17079250
26.

[Summary of the practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners].

Bouma M, Rutten GE, de Grauw WJ, Wiersma T, Goudswaard AN; Nederlands Huisartsen Genootschap.

Ned Tijdschr Geneeskd. 2006 Oct 14;150(41):2251-6. Dutch.

PMID:
17076359
27.

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, De Grauw WJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005061. Review.

PMID:
17054235
28.

[Methods of collecting urine for the determination of microalbuminuria: time for consensus].

Bakker AJ, de Grauw WJ.

Ned Tijdschr Geneeskd. 2004 Oct 9;148(41):2012-5. Review. Dutch.

PMID:
15553996
29.

Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care.

Naushahi MJ, de Grauw WJ, Avery AJ, van Gerwen WH, van de Lisdonk EH, van Weel C.

Diabet Med. 2004 Oct;21(10):1096-101.

PMID:
15384956
30.

Outcomes of audit-enhanced monitoring of patients with type 2 diabetes.

de Grauw WJ, van Gerwen WH, van de Lisdonk EH, van den Hoogen HJ, van den Bosch WJ, van Weel C.

J Fam Pract. 2002 May;51(5):459-64.

PMID:
12019056
31.

Foot ulceration and lower limb amputation in type 2 diabetic patients in dutch primary health care.

Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van Den Hoogen HJ, Rutten GE.

Diabetes Care. 2002 Mar;25(3):570-4.

PMID:
11874949
32.

Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?

de Grauw WJ, van de Lisdonk EH, van Gerwen WH, van den Hoogen HJ, van Weel C.

Br J Gen Pract. 2001 Jul;51(468):527-32.

33.

Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value.

de Grauw WJ, van de Lisdonk EH, van Gerwen WH, Verstappen M, van den Hoogen HJ, Willems JL, van Weel C.

Diabet Med. 2001 Feb;18(2):139-43.

PMID:
11251678
34.
35.

The impact of type 2 diabetes mellitus on daily functioning.

de Grauw WJ, van de Lisdonk EH, Behr RR, van Gerwen WH, van den Hoogen HJ, van Weel C.

Fam Pract. 1999 Apr;16(2):133-9.

PMID:
10381018
36.

Control group characteristics and study outcomes: empirical data from a study on mortality of patients with type 2 diabetes mellitus in Dutch general practice.

de Grauw WJ, van den Hoogen HJ, van de Lisdonk EH, van Gerwen WH, van Weel C.

J Epidemiol Community Health. 1998 Apr;52 Suppl 1:9S-12S.

PMID:
9764264
37.

[A cholesterol-lowering diet is not useful].

Bakx JC, de Grauw WJ, van de Lisdonk EH.

Ned Tijdschr Geneeskd. 1998 Feb 28;142(9):487-8. Dutch. No abstract available.

PMID:
9562769
38.

Screening for microalbuminuria in type 2 diabetic patients: the evaluation of a dipstick test in general practice.

de Grauw WJ, van de Lisdonk EH, van de Hoogen HJ, van Gerwen WH, van den Bosch WJ, Willems JL, van Weel C.

Diabet Med. 1995 Aug;12(8):657-63.

PMID:
7587002
39.

Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice.

de Grauw WJ, van de Lisdonk EH, van den Hoogen HJ, van Weel C.

Diabet Med. 1995 Feb;12(2):117-22.

PMID:
7743757

Supplemental Content

Loading ...
Support Center